These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26683233)

  • 1. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations.
    Cooper SA; Desjardins PJ; Turk DC; Dworkin RH; Katz NP; Kehlet H; Ballantyne JC; Burke LB; Carragee E; Cowan P; Croll S; Dionne RA; Farrar JT; Gilron I; Gordon DB; Iyengar S; Jay GW; Kalso EA; Kerns RD; McDermott MP; Raja SN; Rappaport BA; Rauschkolb C; Royal MA; Segerdahl M; Stauffer JW; Todd KH; Vanhove GF; Wallace MS; West C; White RE; Wu C
    Pain; 2016 Feb; 157(2):288-301. PubMed ID: 26683233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Peirce-Sandner S; Baron R; Bellamy N; Burke LB; Chappell A; Chartier K; Cleeland CS; Costello A; Cowan P; Dimitrova R; Ellenberg S; Farrar JT; French JA; Gilron I; Hertz S; Jadad AR; Jay GW; Kalliomäki J; Katz NP; Kerns RD; Manning DC; McDermott MP; McGrath PJ; Narayana A; Porter L; Quessy S; Rappaport BA; Rauschkolb C; Reeve BB; Rhodes T; Sampaio C; Simpson DM; Stauffer JW; Stucki G; Tobias J; White RE; Witter J
    Pain; 2010 May; 149(2):177-193. PubMed ID: 20207481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Peirce-Sandner S; Burke LB; Farrar JT; Gilron I; Jensen MP; Katz NP; Raja SN; Rappaport BA; Rowbotham MC; Backonja MM; Baron R; Bellamy N; Bhagwagar Z; Costello A; Cowan P; Fang WC; Hertz S; Jay GW; Junor R; Kerns RD; Kerwin R; Kopecky EA; Lissin D; Malamut R; Markman JD; McDermott MP; Munera C; Porter L; Rauschkolb C; Rice ASC; Sampaio C; Skljarevski V; Sommerville K; Stacey BR; Steigerwald I; Tobias J; Trentacosti AM; Wasan AD; Wells GA; Williams J; Witter J; Ziegler D
    Pain; 2012 Jun; 153(6):1148-1158. PubMed ID: 22494920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.
    Gewandter JS; Dworkin RH; Turk DC; Farrar JT; Fillingim RB; Gilron I; Markman JD; Oaklander AL; Polydefkis MJ; Raja SN; Robinson JP; Woolf CJ; Ziegler D; Ashburn MA; Burke LB; Cowan P; George SZ; Goli V; Graff OX; Iyengar S; Jay GW; Katz J; Kehlet H; Kitt RA; Kopecky EA; Malamut R; McDermott MP; Palmer P; Rappaport BA; Rauschkolb C; Steigerwald I; Tobias J; Walco GA
    Pain; 2015 Jul; 156(7):1184-1197. PubMed ID: 25887465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.
    O'Connor AB; Turk DC; Dworkin RH; Katz NP; Colucci R; Haythornthwaite JA; Klein M; O'Brien C; Posner K; Rappaport BA; Reisfield G; Adams EH; Balster RL; Bigelow GE; Burke LB; Comer SD; Cone E; Cowan P; Denisco RA; Farrar JT; Foltin RW; Haddox DJ; Hertz S; Jay GW; Junor R; Kopecky EA; Leiderman DB; McDermott MP; Palmer PP; Raja SN; Rauschkolb C; Rowbotham MC; Sampaio C; Setnik B; Smith SM; Sokolowska M; Stauffer JW; Walsh SL; Zacny JP
    Pain; 2013 Nov; 154(11):2324-2334. PubMed ID: 24148704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement.
    Hohenschurz-Schmidt DJ; Cherkin D; Rice ASC; Dworkin RH; Turk DC; McDermott MP; Bair MJ; DeBar LL; Edwards RR; Farrar JT; Kerns RD; Markman JD; Rowbotham MC; Sherman KJ; Wasan AD; Cowan P; Desjardins P; Ferguson M; Freeman R; Gewandter JS; Gilron I; Grol-Prokopczyk H; Hertz SH; Iyengar S; Kamp C; Karp BI; Kleykamp BA; Loeser JD; Mackey S; Malamut R; McNicol E; Patel KV; Sandbrink F; Schmader K; Simon L; Steiner DJ; Veasley C; Vollert J
    Pain; 2023 Jul; 164(7):1457-1472. PubMed ID: 36943273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.
    Edwards RR; Dworkin RH; Turk DC; Angst MS; Dionne R; Freeman R; Hansson P; Haroutounian S; Arendt-Nielsen L; Attal N; Baron R; Brell J; Bujanover S; Burke LB; Carr D; Chappell AS; Cowan P; Etropolski M; Fillingim RB; Gewandter JS; Katz NP; Kopecky EA; Markman JD; Nomikos G; Porter L; Rappaport BA; Rice ASC; Scavone JM; Scholz J; Simon LS; Smith SM; Tobias J; Tockarshewsky T; Veasley C; Versavel M; Wasan AD; Wen W; Yarnitsky D
    Pain; 2016 Sep; 157(9):1851-1871. PubMed ID: 27152687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.
    Smith SM; Dworkin RH; Turk DC; McDermott MP; Eccleston C; Farrar JT; Rowbotham MC; Bhagwagar Z; Burke LB; Cowan P; Ellenberg SS; Evans SR; Freeman RL; Garrison LP; Iyengar S; Jadad A; Jensen MP; Junor R; Kamp C; Katz NP; Kesslak JP; Kopecky EA; Lissin D; Markman JD; Mease PJ; O'Connor AB; Patel KV; Raja SN; Sampaio C; Schoenfeld D; Singh J; Steigerwald I; Strand V; Tive LA; Tobias J; Wasan AD; Wilson HD
    Pain; 2020 Nov; 161(11):2446-2461. PubMed ID: 32520773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations.
    Gewandter JS; Dworkin RH; Turk DC; McDermott MP; Baron R; Gastonguay MR; Gilron I; Katz NP; Mehta C; Raja SN; Senn S; Taylor C; Cowan P; Desjardins P; Dimitrova R; Dionne R; Farrar JT; Hewitt DJ; Iyengar S; Jay GW; Kalso E; Kerns RD; Leff R; Leong M; Petersen KL; Ravina BM; Rauschkolb C; Rice ASC; Rowbotham MC; Sampaio C; Sindrup SH; Stauffer JW; Steigerwald I; Stewart J; Tobias J; Treede RD; Wallace M; White RE
    Pain; 2014 Sep; 155(9):1683-1695. PubMed ID: 24865794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations.
    Gewandter JS; Dworkin RH; Turk DC; Devine EG; Hewitt D; Jensen MP; Katz NP; Kirkwood AA; Malamut R; Markman JD; Vrijens B; Burke L; Campbell JN; Carr DB; Conaghan PG; Cowan P; Doyle MK; Edwards RR; Evans SR; Farrar JT; Freeman R; Gilron I; Juge D; Kerns RD; Kopecky EA; McDermott MP; Niebler G; Patel KV; Rauck R; Rice ASC; Rowbotham M; Sessler NE; Simon LS; Singla N; Skljarevski V; Tockarshewsky T; Vanhove GF; Wasan AD; Witter J
    J Pain; 2020; 21(9-10):931-942. PubMed ID: 31843583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations.
    Turk DC; Dworkin RH; Burke LB; Gershon R; Rothman M; Scott J; Allen RR; Atkinson HJ; Chandler J; Cleeland C; Cowan P; Dimitrova R; Dionne R; Farrar JT; Haythornthwaite JA; Hertz S; Jadad AR; Jensen MP; Kellstein D; Kerns RD; Manning DC; Martin S; Max MB; McDermott MP; McGrath P; Moulin DE; Nurmikko T; Quessy S; Raja S; Rappaport BA; Rauschkolb C; Robinson JP; Royal MA; Simon L; Stauffer JW; Stucki G; Tollett J; von Stein T; Wallace MS; Wernicke J; White RE; Williams AC; Witter J; Wyrwich KW
    Pain; 2006 Dec; 125(3):208-215. PubMed ID: 17069973
    [No Abstract]   [Full Text] [Related]  

  • 12. Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations.
    Gewandter JS; Smith SM; Dworkin RH; Turk DC; Gan TJ; Gilron I; Hertz S; Katz NP; Markman JD; Raja SN; Rowbotham MC; Stacey BR; Strain EC; Ward DS; Farrar JT; Kroenke K; Rathmell JP; Rauck R; Brown C; Cowan P; Edwards RR; Eisenach JC; Ferguson M; Freeman R; Gray R; Giblin K; Grol-Prokopczyk H; Haythornthwaite J; Jamison RN; Martel M; McNicol E; L Oshinsky M; Sandbrink F; Scholz J; Scranton R; Simon LS; Steiner D; Verburg K; Wasan AD; Wentworth K
    Pain; 2021 Nov; 162(11):2669-2681. PubMed ID: 33863862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the early phase development of new analgesics by human pain biomarkers.
    Arendt-Nielsen L; Hoeck HC
    Expert Rev Neurother; 2011 Nov; 11(11):1631-51. PubMed ID: 22014141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the clinical and experimental characteristics of four acute surgical pain models: dental extraction, bunionectomy, joint replacement, and soft tissue surgery.
    Singla NK; Desjardins PJ; Chang PD
    Pain; 2014 Mar; 155(3):441-456. PubMed ID: 24012952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial designs and models for analgesic medications for acute pain in neonates, infants, toddlers, children, and adolescents: ACTTION recommendations.
    Walco GA; Kopecky EA; Weisman SJ; Stinson J; Stevens B; Desjardins PJ; Berde CB; Krane EJ; Anand KJS; Yaster M; Dampier CD; Dworkin RH; Gilron I; Lynn AM; Maxwell LG; Raja S; Schachtel B; Turk DC
    Pain; 2018 Feb; 159(2):193-205. PubMed ID: 29140927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic relationships for analgesics.
    Suri A; Estes KS; Geisslinger G; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):307-23. PubMed ID: 9266286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting.
    Vincent K; Kennedy S; Stratton P
    Fertil Steril; 2010 Jan; 93(1):62-7. PubMed ID: 18990378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness and acceptability of Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials core outcome set for chronic pain among surveyed neuropathic pain authors.
    Dosenovic S; Nikolic Z; Ivancev B; Jelicic Kadic A; Puljak L
    J Comp Eff Res; 2019 Jul; 8(9):671-683. PubMed ID: 31290689
    [No Abstract]   [Full Text] [Related]  

  • 19. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Wyrwich KW; Beaton D; Cleeland CS; Farrar JT; Haythornthwaite JA; Jensen MP; Kerns RD; Ader DN; Brandenburg N; Burke LB; Cella D; Chandler J; Cowan P; Dimitrova R; Dionne R; Hertz S; Jadad AR; Katz NP; Kehlet H; Kramer LD; Manning DC; McCormick C; McDermott MP; McQuay HJ; Patel S; Porter L; Quessy S; Rappaport BA; Rauschkolb C; Revicki DA; Rothman M; Schmader KE; Stacey BR; Stauffer JW; von Stein T; White RE; Witter J; Zavisic S
    J Pain; 2008 Feb; 9(2):105-21. PubMed ID: 18055266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.
    McGrath PJ; Walco GA; Turk DC; Dworkin RH; Brown MT; Davidson K; Eccleston C; Finley GA; Goldschneider K; Haverkos L; Hertz SH; Ljungman G; Palermo T; Rappaport BA; Rhodes T; Schechter N; Scott J; Sethna N; Svensson OK; Stinson J; von Baeyer CL; Walker L; Weisman S; White RE; Zajicek A; Zeltzer L;
    J Pain; 2008 Sep; 9(9):771-83. PubMed ID: 18562251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.